DexCom
6340 Sequence Drive
San Diego
California
92121
United States
Tel: 858-200-0200
Fax: 858-200-0201
Website: http://www.dexcom.com/
Email: info@dexcom.com
325 articles about DexCom
-
Dexcom Announces Upcoming Conference Presentations - February 23, 2023
2/23/2023
DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming investor conferences.
-
Mednow Launches New Virtual Diabetes Management Program in Partnership With Dexcom
2/2/2023
Mednow Inc. (“Mednow” or the “Company”) (TSXV: MNOW) (OTCQX: MDNWF) announced today the launch of its enhanced Virtual Diabetes Management program, an end-to-end digital diabetes management solution, to enable convenient on-demand access to Dexcom G6 (NASDAQ: DXCM) real-time continuous glucose monitoring (rtCGM) supplies and personalized diabetes care services.
-
Dexcom Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call for February 9, 2023 at 4:30 p.m. Eastern Time
1/24/2023
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its fourth quarter and full year 2022 financial results after market close on Thursday, February 9, 2023.
-
Dexcom G6 Real-Time CGM System Now Available to All Clients With Type 1 Diabetes Covered Under the Non-Insured Health Benefits Program
1/17/2023
Dexcom G6 was the first Continuous Glucose Monitoring (CGM) System to be officially listed by the NIHB Drug Benefit program.
-
Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2022 and Initial 2023 Outlook
1/9/2023
DexCom, Inc. today reported that it expects preliminary, unaudited revenue for the fourth quarter ended December 31, 2022 to be at least $815 million, an increase of 17% over the fourth quarter of 2021 on a reported basis and 20% on an organic 1 basis.
-
Dexcom Appoints Teri Lawver as Chief Commercial Officer
1/9/2023
DexCom, Inc. announced today the appointment of Teri Lawver to the newly created role of chief commercial officer.
-
Dexcom to Present at 41st Annual J.P. Morgan Healthcare Conference
1/3/2023
DexCom, Inc. announced that Kevin Sayer, Chairman, President and Chief Executive Officer, will present an update on the company at the 41st annual J.P. Morgan Healthcare Conference on January 9, 2023.
-
Dexcom Canada Partners With Green Shield and The Health Depot to Offer Plan Members a Comprehensive Digital Diabetes Care Experience
12/12/2022
Dexcom, Inc. (NASDAQ: DXCM), a leader in real-time continuous glucose monitoring (rtCGM), announced today its partnership with Green Shield and The Health Depot digital pharmacy to provide Green Shield plan members with convenient access to the Dexcom G6 rtCGM System combined with virtual diabetes coaching support.
-
Dexcom G7 Receives FDA Clearance: The Most Accurate Continuous Glucose Monitoring System Cleared in the U.S.
12/8/2022
Dexcom G7 is now cleared in the U.S. for people with all Types of diabetes ages two years and older, giving more people than ever access to a powerfully simple diabetes management solution.
-
Dexcom Announces Upcoming Conference Presentation - November 22, 2022
11/22/2022
DexCom, Inc. announced that Matt Dolan, Executive Vice President, Strategy, Corporate Development and Dexcom Labs, will present an update on the company at the Piper Sandler 34th Annual Healthcare Conference on Wednesday, November 30, 2022 at 8:30am.
-
Dexcom Reports Third Quarter 2022 Financial Results
10/27/2022
DexCom, Inc. reported its financial results as of and for the quarter ended September 30, 2022.
-
Dexcom Schedules Third Quarter 2022 Earnings Release and Conference Call for October 27, 2022 at 4:30 p.m. Eastern Time.
9/29/2022
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2022 financial results after market close on Thursday, October 27, 2022.
-
Dexcom Announces Upcoming Conference Presentations in September 2022
9/1/2022
DexCom, Inc. announced that Jereme Sylvain, Executive Vice President and Chief Financial Officer, will present an update on the company at the following upcoming investor conferences.
-
Dexcom Announces Upcoming Conference Presentation - Aug 03, 2022
8/3/2022
DexCom, Inc. announced that Jereme Sylvain, Executive Vice President and Chief Financial Officer, will present an update on the company at the Canaccord Genuity 42nd Annual Growth Conference on Wednesday, August 10, 2022 at 10:30am.
-
Dexcom Reports Second Quarter 2022 Financial Results
7/28/2022
DexCom, Inc. reported its financial results as of and for the quarter ended June 30, 2022.
-
Dexcom Schedules Second Quarter 2022 Earnings Release and Conference Call for July 28, 2022 at 4:30 p.m. Eastern Time.
6/30/2022
DexCom, Inc. announced that it plans to release its second quarter 2022 financial results after market close on Thursday, July 28, 2022.
-
Dexcom to Showcase Expanded CGM Portfolio and Industry-leading Connectivity at 82nd Scientific Sessions of the American Diabetes Association
6/2/2022
Dexcom to Showcase Expanded CGM Portfolio and Industry-leading Connectivity at 82nd Scientific Sessions of the American Diabetes Association.
-
Prince Edward Island Becomes a National Leader in Providing Coverage for Dexcom G6 Continuous Glucose Monitoring System for Canadians With Diabetes
6/1/2022
Dexcom, Inc. announced that people with type 1 and type 2 diabetes age two and over on multiple daily injections of insulin or who use an insulin pump may now be eligible for public coverage of the Dexcom G6 CGM System through Prince Edward Island’s Diabetes Glucose Sensor Program.
-
Dexcom Issues Statement on Recent Market Speculation
5/31/2022
DexCom, Inc. (NASDAQ:DXCM) today issued the following statement in response to recent media and market speculation: “Like many companies, Dexcom’s Board and management team regularly review opportunities to enhance stockholder value and create benefits for customers, including through mergers and acquisitions.
-
Dexcom Announces Upcoming Conference Presentations - May 10, 2022
5/10/2022
DexCom, Inc. announced that Jereme Sylvain, Executive Vice President and Chief Financial Officer, will present an update on the company at the following upcoming investor conferences: BofA Securities 2022 Healthcare Conference on Wednesday, May 11, 2022 at 5:40pm.